Policy and Advocacy Shorts with Keith Wonnacott, PhD

Поделиться
HTML-код
  • Опубликовано: 8 сен 2024
  • Keith Wonnacott, PhD, Vice President of Regulatory Affairs at Lexeo Therapeutics, shares insights on ASGCT's role in connecting academia and industry, and discusses the evolution of regulatory approaches in cell and gene therapy.
  • НаукаНаука

Комментарии •